Last updated: April 9, 2025
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anemia
Red Blood Cell Disorders
Lupus
Treatment
Brain function and psychological assessment
Clinical Study ID
NCT06921980
QTJC2025011
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of AIHA
Subjects will receive cell therapy such as CAR T-cell therapy
Male or female, aged 18-65 years
Willing and able to comply with the requirements for this study and written informedconsent
Exclusion
Exclusion Criteria:
History of psychiatric illness
History of severe brain disease
Subjects that the investigator believes have other reasons that make them unsuitablefor inclusion in this study
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Brain function and psychological assessment
Phase:
Study Start date:
February 25, 2025
Estimated Completion Date:
December 31, 2026
Connect with a study center
Regenerative Medicine Center
Tianjin, Tianjin
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.